Ascentage Pharma Group Intl ADR
(AAPG)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 06-2025 | 12-2024 | 06-2024 | 12-2023 | |
| Cash Flows From Operating Activities | ||||
| Net Income | N/A | -54,149 | N/A | -128,366 |
| Depreciation Amortization | N/A | 11,239 | N/A | 11,224 |
| Other Working Capital | N/A | 15,202 | N/A | -1,259 |
| Other Operating Activity | 0 | 12,452 | -48,766 | 18,489 |
| Operating Cash Flow | $N/A | $-15,256 | $-48,766 | $-99,912 |
| Cash Flows From Investing Activities | ||||
| PPE Investments | N/A | -3,328 | -2,273 | -6,343 |
| Other Investing Activity | 0 | -46,271 | -15,791 | 9,360 |
| Investing Cash Flow | $N/A | $-49,599 | $-18,064 | $3,017 |
| Cash Flows From Financing Activities | ||||
| Other Financing Activity | 0 | 43,122 | 54,616 | 50,742 |
| Financing Cash Flow | $N/A | $43,122 | $54,616 | $50,742 |
| Exchange Rate Effect | N/A | 1,875 | 433 | 3,827 |
| Beginning Cash Position | N/A | 142,212 | 142,840 | 185,166 |
| End Cash Position | N/A | 122,354 | 131,059 | 142,840 |
| Net Cash Flow | $N/A | $-19,858 | $-11,781 | $-42,326 |
| Free Cash Flow | ||||
| Operating Cash Flow | N/A | -15,256 | -48,766 | -99,912 |
| Free Cash Flow | 0 | -15,256 | -48,766 | -99,912 |